Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT07021157
A Study to Evaluate the Safety, Tolerability and PK of SK-08
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 9, 2025
Completion: Aug 7, 2025